Invex Therapeutics
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - Industrial WAInvex operates in the biopharmaceutical industry, seeking to develop efficacious treatments for neurological conditions resulting from raised intracranial pressure (ICP). ICP is a serious issue in a range of neurological conditions, including idiopathic intracranial hypertension, traumatic brain injury or acute stroke.
The company listed on the ASX in July 2019.
Contact Details
Level 1, 38 Rowland Street, SUBIACO WA 6008
08 6382 0137
Lists and Charts
Public Companies - Industrial WA list sponsored by
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 175th |  | Invex Therapeutics | $459k |
| 191st |  | Pura Vida Energy | $74k |
| 192nd | | Connected IO | $24k |
| 194th | | 4DS Memory | $0 |
| 195th |  | HearMeOut | $0 |
202 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 45th | 4DS Memory | 177% | 7% |
| 714th | Connected IO | 0% | 0% |
| 1865th | Invex Therapeutics | -83% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Company Activity
| NEW ROLE: Carol Parish, | 04 Sep 2023 |
| ECM DEAL: New deal has been added | 15 Jan 2021 |
| REMUNERATION UPDATE: Narelle Warren, Chief Financial Officer, Company Secretary | 02 Nov 2020 |
| NEW ROLE: Tom Duthy, Executive Director | 10 Oct 2020 |
